Suppr超能文献

血红素加氧酶-1 在移植中的作用。

Role of heme oxygenase-1 in transplantation.

机构信息

Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria.

出版信息

Transpl Int. 2010 Nov;23(11):1071-81. doi: 10.1111/j.1432-2277.2010.01158.x. Epub 2010 Aug 31.

Abstract

Heme oxygenase-1 (HO-1) is the rate-limiting enzyme in heme catabolism that converts heme to Fe++, carbon monoxide and biliverdin. HO-1 acts anti-inflammatory and modulates apoptosis in many pathological conditions. In transplantation, HO-1 is overexpressed in organs during brain death, when undergoing ischemic damage and rejection. However, intentionally induced, it ameliorates pathological processes like ischemia reperfusion injury, allograft, xenograft or islet rejection, facilitates donor specific tolerance and alleviates chronic allograft changes. We herein consistently summarize the huge amount of data on HO-1 and transplantation that have been generated in multiple laboratories during the last 15years and suggest possible clinical implications and applications for the near future.

摘要

血红素加氧酶-1(HO-1)是血红素分解代谢的限速酶,可将血红素转化为 Fe++、一氧化碳和胆绿素。HO-1 在许多病理条件下具有抗炎和调节细胞凋亡的作用。在移植中,HO-1 在脑死亡期间、发生缺血损伤和排斥反应时在器官中过度表达。然而,在诱导时,它可以改善缺血再灌注损伤、同种异体移植物、异种移植物或胰岛排斥等病理过程,促进供体特异性耐受,并减轻慢性移植物改变。我们在此一致总结了过去 15 年来多个实验室在 HO-1 和移植方面产生的大量数据,并提出了其在不久的将来可能的临床意义和应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验